TC
BBH icon

Telemus Capital’s VanEck Biotech ETF BBH Stock Holding History

Telemus Capital’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$503K Sell
3,045
-75
-2% -$11.5K 0.04% 239
2023
Q3 		$486K Hold
3,120
– – 0.05% 219
2023
Q2 		$487K Sell
3,120
-30
-1% -$4.79K 0.04% 228
2023
Q1 		$511K Sell
3,150
-27
-0.8% -$4.37K 0.05% 217
2022
Q4 		$517K Buy
3,177
+27
+0.9% +$4.28K 0.05% 222
2022
Q3 		$443K Sell
3,150
-88
-3% -$13.3K 0.05% 213
2022
Q2 		$472K Buy
3,238
+88
+3% +$13.1K 0.05% 240
2022
Q1 		$511K Buy
3,150
+5
+0.2% +$810 0.04% 227
2021
Q4 		$595K Hold
3,145
– – 0.05% 230
2021
Q3 		$636K Buy
3,145
+10
+0.3% +$2.1K 0.05% 214
2021
Q2 		$632K Buy
3,135
+65
+2% +$12.1K 0.05% 225
2021
Q1 		$545K Buy
3,070
+20
+0.7% +$3.62K 0.04% 263
2020
Q4 		$518K Buy
3,050
+125
+4% +$20.6K 0.04% 248
2020
Q3 		$477K Sell
2,925
-34
-1% -$5.53K 0.04% 306
2020
Q2 		$495K Sell
2,959
-100
-3% -$15.2K 0.04% 276
2020
Q1 		$492K Sell
3,059
-1,511
-33% -$204K 0.04% 254
2019
Q4 		$637K Buy
4,570
+40
+0.9% +$5.26K 0.05% 222
2019
Q3 		$534K Hold
4,530
– – 0.04% 236
2019
Q2 		$554K Sell
4,530
-425
-9% -$52.4K 0.05% 225
2019
Q1 		$637K Hold
4,955
– – 0.05% 243
2018
Q4 		$549K Hold
4,955
– – 0.04% 256
2018
Q3 		$674K Hold
4,955
– – 0.05% 259
2018
Q2 		$595K Buy
+4,955
New +$584K 0.05% 268
2018
Q1 		– Sell
-1,030
Closed -$128K – 417
2017
Q4 		$128K Buy
+1,030
New +$132K 0.01% 411

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CIG
Consolidated Investment Group Englewood, Colorado $922M AUM 28.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Telemus Capital's BBH Position: Q4 2023 in Review

Telemus Capital reduced its VanEck Biotech ETF (BBH) stake by 2.4% in Q4 2023, selling an estimated $11.5K and leaving 3,045 shares worth $503K. The position accounts for 0.04% of the portfolio, ranked #239.

Telemus Capital first reported a position in BBH in Q4 2017 and has held it in 24 quarters since. The position peaked at $674K in Q3 2018. 116 funds tracked by Wall St. Rank hold BBH as of Q4 2023.

  • Telemus Capital held 3,045 shares of VanEck Biotech ETF worth $503K as of Q4 2023.
  • Telemus Capital sold 75 VanEck Biotech ETF shares in Q4 2023, an estimated $11.5K.
  • VanEck Biotech ETF made up 0.04% of Telemus Capital's portfolio in Q4 2023, its #239 holding.
  • Telemus Capital first reported a position in VanEck Biotech ETF in Q4 2017 and has held it in 24 quarters since.
  • Telemus Capital's VanEck Biotech ETF position peaked at $674K in Q3 2018.
  • 116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2023.

Based on Telemus Capital's 13F filing for Q4 2023, filed 1 Feb 2024.